Hints and tips:
Related Special Reports
...Health authorities had also hoped it could help sway sceptics who preferred not to receive an mRNA vaccine, though demand has since collapsed....
...While some investors are sceptical of companies without long-term growth plans, she said Moderna had met every challenge....
...Przybelski, at UW Health, said about half his patients were initially refused by Medicare Advantage plans for PET scan coverage, adding that “it normally involves a long phone call” to get scans approved...
...In a separate 2020 New Jersey court case, a crypto entrepreneur accused of running a Ponzi scheme used his Aurae card to transfer $100mn between 2018 and 2019....
...Apple was recently forced to make a series of U-turns by the EU regulator over its plan to comply with a new competition law, and has already changed parts of its business model in the bloc as a result....
...were put on some form of performance management plan or facing dismissal....
...US health insurer Cigna has abandoned plans to merge with Humana, a blockbuster transaction that would have created a $140bn insurance giant, according to people familiar with the matter....
...From: Rutherford@Monkwellstrategy To: Platinumclientlist I just want to share some news about a couple of upcoming events....
...Shares in Pfizer fell 5 per cent in in New York on Friday after the group said more than half of the participants in its clinical trial for the new drug had dropped out because of side effects....
...US data analytics group Palantir has secured an NHS England contract worth £330mn to develop a new patient data platform, the health service announced on Tuesday....
...New York-listed shares lost 8.2 per cent shortly after the open, after losing 49 per cent this year....
...David, a 51-year-old recovering addict from New Jersey, credits Williamsville with saving his life....
...Pfizer and BioNTech each receive half of the gross profits of the vaccine. The US group plans to cut about $1bn in costs this year....
...Roche plans to buy immunology company Telavant from Roivant Sciences and Pfizer for more than $7bn, as the drugmaker’s new chief executive seeks to replenish its drug pipeline....
...With the new building, MSD plans to bring together scientists scattered at several sites around the King’s Cross area and more than double the number of its researchers in London....
...“searching for promising second or third new customers”....
...But early indications of MA enrolment for 2024 have not been great, and if that plays out, Cigna’s greater exposure to commercial health plans may turn into a relative advantage....
...heart of its business plan — and luxury showrooms....
...In 2020, Pfizer spun off its generics business Upjohn, combining it with Mylan to form Viatris, while Johnson & Johnson, GSK, Pfizer and Novartis have all shed their consumer health businesses selling over-the-counter...
...Nomura’s offices are in downtown Manhattan, but McElligott’s home is about 30 miles away in New Jersey....
...But will a new generation replace them?...
...The New Jersey pharmaceutical titan’s share price has doubled in the past five years, well ahead of the wider S&P 500 index....
...The case was filed in Middlesex county, New Jersey, and lawyers working for talc claimants say it could be the first of many claims filed against Kenvue and other J&J divisions not previously named in lawsuits...
...J&J will today ask a bankruptcy judge in New Jersey to again place a stay on all the lawsuits to enable it to finalise a restructuring plan....
...The data allows caregivers to make accurate predictions of health conditions, such as dementia or mobility problems, from which they can create nursing plans to reduce risk of such diseases — instead of...
International Edition